Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Steven Ahrendt to Humans

This is a "connection" page, showing publications Steven Ahrendt has written about Humans.

 
Connection Strength
 
 
 
0.196
 
  1. Torphy RJ, Stewart C, Sharma P, Halpern AL, Oase K, Herter W, Bartsch C, Friedman C, Del Chiaro M, Schulick RD, Gleisner A, McCarter MD, Ahrendt SA. Dextrose-Containing Carrier Solution for Hyperthermic Intraperitoneal Chemotherapy: Increased Intraoperative Hyperglycemia and Postoperative Complications. Ann Surg Oncol. 2020 Dec; 27(13):4874-4882.
    View in: PubMed
    Score: 0.017
  2. Khorana AA, Hu YC, Ryan CK, Komorowski RA, Hostetter G, Ahrendt SA. Vascular endothelial growth factor and DPC4 predict adjuvant therapy outcomes in resected pancreatic cancer. J Gastrointest Surg. 2005 Sep-Oct; 9(7):903-11.
    View in: PubMed
    Score: 0.006
  3. Khomiak A, Ghaffar S, Rodriguez Franco S, Ziogas IA, Yee EJ, Franklin O, Cumbler E, Chauhan A, McCarter MD, Gleisner AL, Ahrendt S, Del Chiaro M, Schulick RD, Mungo B. Survival Outcomes of Cytoreductive Surgery with HIPEC in Gastric Adenocarcinoma: A National Cancer Database Study. Ann Surg Oncol. 2024 Dec; 31(13):8549-8559.
    View in: PubMed
    Score: 0.006
  4. Yee EJ, Torphy RJ, Myers EK, Meguid C, Franklin O, Sugawara T, Franco SR, Clark TJ, Mungo B, Ahrendt SA, Schulick RD, Del Chiaro M, McCarter MM. Dynamic Anthropometrics in Pancreatic Cancer: Associations Between Body Composition Changes During Neoadjuvant Therapy and Survival Outcomes After Resection. Ann Surg Oncol. 2024 Nov; 31(12):8340-8351.
    View in: PubMed
    Score: 0.006
  5. Yee EJ, Torphy RJ, Thielen ON, Easwaran L, Franklin O, Sugawara T, Bartsch C, Garduno N, McCarter MM, Ahrendt SA, Schulick RD, Del Chiaro M. Radiologic Occult Metastases in Pancreatic Cancer: Analysis of Risk Factors and Survival Outcomes in the Age of Contemporary Neoadjuvant Multi-agent Chemotherapy. Ann Surg Oncol. 2024 Sep; 31(9):6127-6137.
    View in: PubMed
    Score: 0.006
  6. Wach MM, Nunns G, Hamed A, Derby J, Jelinek M, Tatsuoka C, Holtzman MP, Zureikat AH, Bartlett DL, Ahrendt SA, Pingpank JF, Choudry MHA, Ongchin M. Normal CEA Levels After Neoadjuvant Chemotherapy and Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion Predict Improved Survival from Colorectal Peritoneal Metastases. Ann Surg Oncol. 2024 Apr; 31(4):2391-2400.
    View in: PubMed
    Score: 0.005
  7. Hu YC, Komorowski RA, Graewin S, Hostetter G, Kallioniemi OP, Pitt HA, Ahrendt SA. Thymidylate synthase expression predicts the response to 5-fluorouracil-based adjuvant therapy in pancreatic cancer. Clin Cancer Res. 2003 Sep 15; 9(11):4165-71.
    View in: PubMed
    Score: 0.005
  8. Ahrendt SA, Hu Y, Buta M, McDermott MP, Benoit N, Yang SC, Wu L, Sidransky D. p53 mutations and survival in stage I non-small-cell lung cancer: results of a prospective study. J Natl Cancer Inst. 2003 Jul 02; 95(13):961-70.
    View in: PubMed
    Score: 0.005
  9. Ahrendt SA, Pitt HA. Surgical management of pancreatic cancer. Oncology (Williston Park). 2002 Jun; 16(6):725-34; discussion 734, 736-8, 740, 743.
    View in: PubMed
    Score: 0.005
  10. Oba A, Wu YHA, Colborn KL, Karam SD, Meguid C, Al-Musawi MH, Bao QR, Gleisner AL, Ahrendt S, Schulick RD, Del Chiaro M. Comparing neoadjuvant chemotherapy with or without radiation therapy for pancreatic ductal adenocarcinoma: National Cancer Database cohort analysis. Br J Surg. 2022 04 19; 109(5):450-454.
    View in: PubMed
    Score: 0.005
  11. Ahrendt SA, Yang SC, Wu L, Roig CM, Russell P, Westra WH, Jen J, Brock MV, Heitmiller RF, Sidransky D. Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: preliminary results of a prospective study. J Thorac Cardiovasc Surg. 2002 Mar; 123(3):466-73; discussion 473-4.
    View in: PubMed
    Score: 0.005
  12. Ahrendt SA, Komorowski RA, Demeure MJ, Wilson SD, Pitt HA. Cystic pancreatic neuroendocrine tumors: is preoperative diagnosis possible? J Gastrointest Surg. 2002 Jan-Feb; 6(1):66-74.
    View in: PubMed
    Score: 0.005
  13. Oba A, Croce C, Hosokawa P, Meguid C, Torphy RJ, Al-Musawi MH, Ahrendt S, Gleisner A, Schulick RD, Del Chiaro M. Prognosis Based Definition of Resectability in Pancreatic Cancer: A Road Map to New Guidelines. Ann Surg. 2022 01 01; 275(1):175-181.
    View in: PubMed
    Score: 0.005
  14. Torphy RJ, Friedman C, Halpern AL, Ahrendt SA, McCarter MD, Del Chiaro M, Schulick RD, Gleisner A. Implementation of Minimally Invasive Pancreaticoduodenectomy at Low and High-Volume Centers. J Surg Res. 2021 12; 268:720-728.
    View in: PubMed
    Score: 0.005
  15. Oba A, Wu YHA, Lieu CH, Meguid C, Colborn KL, Beaty L, Al-Musawi MH, Davis SL, Leal AD, Purcell T, King G, Wooten ES, Fujiwara Y, Goodman KA, Schefter T, Karam SD, Gleisner AL, Ahrendt S, Leong S, Messersmith WA, Schulick RD, Del Chiaro M. Outcome of neoadjuvant treatment for pancreatic cancer in elderly patients: comparative, observational cohort study. Br J Surg. 2021 08 19; 108(8):976-982.
    View in: PubMed
    Score: 0.005
  16. Ahrendt SA, Brown HM, Komorowski RA, Zhu YR, Wilson SD, Erickson BA, Ritch PS, Pitt HA, Demeure MJ. p21WAF1 expression is associated with improved survival after adjuvant chemoradiation for pancreatic cancer. Surgery. 2000 Oct; 128(4):520-30.
    View in: PubMed
    Score: 0.004
  17. Mungo B, Croce C, Oba A, Ahrendt S, Gleisner A, Friedman C, Schulick RD, Del Chiaro M. Controversial Role of Adjuvant Therapy in Node-Negative Invasive Intraductal Papillary Mucinous Neoplasm. Ann Surg Oncol. 2021 Mar; 28(3):1533-1542.
    View in: PubMed
    Score: 0.004
  18. Wu YHA, Samuels JM, Harnke B, Negrini D, Al-Musawi MH, Meguid C, Ahrendt S, Schulick RD, Del Chiaro M, Oba A. Multifocal/diffuse pancreatic serous cystic neoplasms: Systematic review with a new case. Pancreatology. 2020 Jul; 20(5):902-909.
    View in: PubMed
    Score: 0.004
  19. Ahrendt SA, Pitt HA, Nakeeb A, Klein AS, Lillemoe KD, Kalloo AN, Cameron JL. Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis. J Gastrointest Surg. 1999 Jul-Aug; 3(4):357-67; discussion 367-8.
    View in: PubMed
    Score: 0.004
  20. Torphy RJ, Chapman BC, Friedman C, Nguyen C, Bartsch CG, Meguid C, Ahrendt SA, McCarter MD, Del Chiaro M, Schulick RD, Edil BH, Gleisner A. Quality of Life Following Major Laparoscopic or Open Pancreatic Resection. Ann Surg Oncol. 2019 Sep; 26(9):2985-2993.
    View in: PubMed
    Score: 0.004
  21. Beane JD, Wilson GC, Sutton JM, Shuai Y, Ramalingam L, Jones HL, Pingpank JF, Holtzman MP, Zureikat AJ, Ahrendt SA, Zeh HJ, Bartlett DL, Choudry HA. Pleuropulmonary Recurrence Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Appendiceal Pseudomyxoma Peritonei. Ann Surg Oncol. 2019 May; 26(5):1429-1436.
    View in: PubMed
    Score: 0.004
  22. Amblard I, Mercier F, Bartlett DL, Ahrendt SA, Lee KW, Zeh HJ, Levine EA, Baratti D, Deraco M, Piso P, Morris DL, Rau B, Tentes AAK, Tuech JJ, Quenet F, Akaishi E, Pocard M, Yonemura Y, Lorimier G, Delroeux D, Villeneuve L, Glehen O, Passot G. Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups. Eur J Surg Oncol. 2018 09; 44(9):1378-1383.
    View in: PubMed
    Score: 0.004
  23. Ahrendt SA, Pitt HA, Kalloo AN, Venbrux AC, Klein AS, Herlong HF, Coleman J, Lillemoe KD, Cameron JL. Primary sclerosing cholangitis: resect, dilate, or transplant? Ann Surg. 1998 Mar; 227(3):412-23.
    View in: PubMed
    Score: 0.004
  24. Low CA, Bovbjerg DH, Ahrendt S, Choudry MH, Holtzman M, Jones HL, Pingpank JF, Ramalingam L, Zeh HJ, Zureikat AH, Bartlett DL. Fitbit step counts during inpatient recovery from cancer surgery as a predictor of readmission. Ann Behav Med. 2018 01 05; 52(1):88-92.
    View in: PubMed
    Score: 0.004
  25. Ahrendt SA, Yang SC, Wu L, Westra WH, Jen J, Califano JA, Sidransky D. Comparison of oncogene mutation detection and telomerase activity for the molecular staging of non-small cell lung cancer. Clin Cancer Res. 1997 Jul; 3(7):1207-14.
    View in: PubMed
    Score: 0.003
  26. Dhir M, Choudry HA, Holtzman MP, Pingpank JF, Ahrendt SA, Zureikat AH, Hogg ME, Bartlett DL, Zeh HJ, Singhi AD, Bahary N. Impact of genomic profiling on the treatment and outcomes of patients with advanced gastrointestinal malignancies. Cancer Med. 2017 01; 6(1):195-206.
    View in: PubMed
    Score: 0.003
  27. Dhir M, Ramalingam L, Shuai Y, Pakrafter S, Jones HL, Hogg ME, Zureikat AH, Holtzman MP, Ahrendt SA, Bahary N, Pingpank JF, Zeh HJ, Bartlett DL, Choudry HA. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Adolescent and Young Adults with Peritoneal Metastases. Ann Surg Oncol. 2017 Apr; 24(4):875-883.
    View in: PubMed
    Score: 0.003
  28. Kermanshahi TR, Magge D, Choudry H, Ramalingam L, Zhu B, Pingpank J, Ahrendt S, Holtzman M, Zeh H, Bartlett D, Zureikat A, Pai RK. Mucinous and Signet Ring Cell Differentiation Affect Patterns of Metastasis in Colorectal Carcinoma and Influence Survival. Int J Surg Pathol. 2017 Apr; 25(2):108-117.
    View in: PubMed
    Score: 0.003
  29. Radomski M, Pai RK, Shuai Y, Ramalingam L, Jones H, Holtzman MP, Ahrendt SA, Pingpank JF, Zeh HJ, Bartlett DL, Choudry HA. Curative Surgical Resection as a Component of Multimodality Therapy for Peritoneal Metastases from Goblet Cell Carcinoids. Ann Surg Oncol. 2016 12; 23(13):4338-4343.
    View in: PubMed
    Score: 0.003
  30. Low CA, Bovbjerg DH, Ahrendt S, Alhelo S, Choudry H, Holtzman M, Jones HL, Pingpank JF, Ramalingam L, Zeh HJ, Zureikat AH, Bartlett DL. Depressive Symptoms in Patients Scheduled for Hyperthermic Intraperitoneal Chemotherapy With Cytoreductive Surgery: Prospective Associations With Morbidity and Mortality. J Clin Oncol. 2016 Apr 10; 34(11):1217-22.
    View in: PubMed
    Score: 0.003
  31. Wagner PL, Austin F, Zenati M, Jaech A, Mavanur A, Ramalingam L, Jones HL, Holtzman MP, Ahrendt SA, Zureikat AH, Pingpank JF, Zeh HJ, Bartlett DL, Choudry HA. Oncologic Risk Stratification Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Appendiceal Carcinomatosis. Ann Surg Oncol. 2016 May; 23(5):1587-93.
    View in: PubMed
    Score: 0.003
  32. Polanco PM, Ding Y, Knox JM, Ramalingam L, Jones H, Hogg ME, Zureikat AH, Holtzman MP, Pingpank J, Ahrendt S, Zeh HJ, Bartlett DL, Choudry HA. Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Patients with High-Grade, High-Volume Disseminated Mucinous Appendiceal Neoplasms. Ann Surg Oncol. 2016 Feb; 23(2):382-90.
    View in: PubMed
    Score: 0.003
  33. Wagner P, Boone B, Ramalingam L, Jones H, Zureikat A, Holtzman M, Ahrendt S, Pingpank J, Zeh H, Choudry H, Bartlett D. Histologic and Immunohistochemical Alterations Associated with Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S588-95.
    View in: PubMed
    Score: 0.003
  34. Polanco PM, Ding Y, Knox JM, Ramalingam L, Jones H, Hogg ME, Zureikat AH, Holtzman MP, Pingpank J, Ahrendt S, Zeh HJ, Bartlett DL, Choudry HA. Institutional learning curve of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for peritoneal malignancies. Ann Surg Oncol. 2015 May; 22(5):1673-9.
    View in: PubMed
    Score: 0.003
  35. Ahrendt SA, Fox-Talbot MK, Kaufman HS, Lillemoe KD, Lipsett PA, Pitt HA. Characterization of a small vesicular cholesterol carrier in human gallbladder bile. Ann Surg. 1994 Nov; 220(5):635-43.
    View in: PubMed
    Score: 0.003
  36. Downs-Canner S, Ding Y, Magge DR, Jones H, Ramalingam L, Zureikat A, Holtzman M, Ahrendt S, Pingpank J, Zeh HJ, Bartlett DL, Choudry HA. A comparative analysis of postoperative pancreatic fistulas after surgery with and without hyperthermic intraperitoneal chemoperfusion. Ann Surg Oncol. 2015 May; 22(5):1651-7.
    View in: PubMed
    Score: 0.003
  37. Low CA, Bovbjerg DH, Jenkins FJ, Ahrendt SA, Choudry HA, Holtzman MP, Jones HL, Pingpank JF, Ramalingam L, Zeh HJ, Zureikat AH, Bartlett DL. Preoperative inflammatory biomarkers and neurovegetative symptoms in peritoneal carcinomatosis patients. Brain Behav Immun. 2014 Nov; 42:65-8.
    View in: PubMed
    Score: 0.003
  38. Polanco PM, Sanchez AI, Ramalingam L, Jones H, Zureikat A, Holtzman M, Ahrendt S, Pingpank J, Zeh HJ, Bartlett DL, Choudry HA. Does obesity affect outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for disseminated mucinous appendiceal neoplasms? Ann Surg Oncol. 2014 Nov; 21(12):3963-9.
    View in: PubMed
    Score: 0.003
  39. Singhi AD, Davison JM, Choudry HA, Pingpank JF, Ahrendt SA, Holtzman MP, Zureikat AH, Zeh HJ, Ramalingam L, Mantha G, Nikiforova M, Bartlett DL, Pai RK. GNAS is frequently mutated in both low-grade and high-grade disseminated appendiceal mucinous neoplasms but does not affect survival. Hum Pathol. 2014 Aug; 45(8):1737-43.
    View in: PubMed
    Score: 0.003
  40. Davison JM, Choudry HA, Pingpank JF, Ahrendt SA, Holtzman MP, Zureikat AH, Zeh HJ, Ramalingam L, Zhu B, Nikiforova M, Bartlett DL, Pai RK. Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade. Mod Pathol. 2014 Nov; 27(11):1521-39.
    View in: PubMed
    Score: 0.003
  41. Magge D, Zenati MS, Austin F, Mavanur A, Sathaiah M, Ramalingam L, Jones H, Zureikat AH, Holtzman M, Ahrendt S, Pingpank J, Zeh HJ, Bartlett DL, Choudry HA. Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis. Ann Surg Oncol. 2014 Apr; 21(4):1159-65.
    View in: PubMed
    Score: 0.003
  42. Winer J, Zenati M, Ramalingam L, Jones H, Zureikat A, Holtzman M, Lee K, Ahrendt S, Pingpank J, Zeh HJ, Bartlett DL, Choudry HA. Impact of aggressive histology and location of primary tumor on the efficacy of surgical therapy for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol. 2014 May; 21(5):1456-62.
    View in: PubMed
    Score: 0.003
  43. Magge D, Zenati M, Mavanur A, Winer J, Ramalingam L, Jones H, Zureikat A, Holtzman M, Lee K, Ahrendt S, Pingpank J, Zeh HJ, Bartlett DL, Choudry HA. Aggressive locoregional surgical therapy for gastric peritoneal carcinomatosis. Ann Surg Oncol. 2014 May; 21(5):1448-55.
    View in: PubMed
    Score: 0.003
  44. Wagner PL, Austin F, Maduekwe U, Mavanur A, Ramalingam L, Jones HL, Holtzman MP, Ahrendt SA, Zureikat AH, Pingpank JF, Zeh HJ, Bartlett DL, Choudry HA. Extensive cytoreductive surgery for appendiceal carcinomatosis: morbidity, mortality, and survival. Ann Surg Oncol. 2013 Apr; 20(4):1056-62.
    View in: PubMed
    Score: 0.003
  45. Baumgartner JM, Ahrendt SA, Pingpank JF, Holtzman MP, Ramalingam L, Jones HL, Zureikat AH, Zeh HJ, Bartlett DL, Choudry HA. Aggressive locoregional management of recurrent peritoneal sarcomatosis. J Surg Oncol. 2013 Mar; 107(4):329-34.
    View in: PubMed
    Score: 0.003
  46. Wagner PL, Austin F, Sathaiah M, Magge D, Maduekwe U, Ramalingam L, Jones HL, Holtzman MP, Ahrendt SA, Zureikat AH, Pingpank JF, Zeh HJ, Bartlett DL, Choudry HA. Significance of serum tumor marker levels in peritoneal carcinomatosis of appendiceal origin. Ann Surg Oncol. 2013 Feb; 20(2):506-14.
    View in: PubMed
    Score: 0.002
  47. Austin F, Mavanur A, Sathaiah M, Steel J, Lenzner D, Ramalingam L, Holtzman M, Ahrendt S, Pingpank J, Zeh HJ, Bartlett DL, Choudry HA. Aggressive management of peritoneal carcinomatosis from mucinous appendiceal neoplasms. Ann Surg Oncol. 2012 May; 19(5):1386-93.
    View in: PubMed
    Score: 0.002
  48. Franko J, Gusani NJ, Holtzman MP, Ahrendt SA, Jones HL, Zeh HJ, Bartlett DL. Multivisceral resection does not affect morbidity and survival after cytoreductive surgery and chemoperfusion for carcinomatosis from colorectal cancer. Ann Surg Oncol. 2008 Nov; 15(11):3065-72.
    View in: PubMed
    Score: 0.002
  49. Harden SV, Tokumaru Y, Westra WH, Goodman S, Ahrendt SA, Yang SC, Sidransky D. Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients. Clin Cancer Res. 2003 Apr; 9(4):1370-5.
    View in: PubMed
    Score: 0.001
  50. Brown HM, Ahrendt SA, Komorowski RA, Doffek KM, Wilson SD, Demeure MJ. Immunohistochemistry and molecular detection of nodal micrometastases in pancreatic cancer. J Surg Res. 2001 Feb; 95(2):141-6.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)